Paid Asthma Clinical Trials
Asthma clinical trials now enrolling. Access new biologics for severe asthma. Compensation up to $2,800. Studies for adults and adolescents with uncontrolled asthma.
Compensation
$1,500 - $2,800
Duration
24-52 weeks
Phase
Phase II/III
FDA Regulated
IRB Approved
GCP Certified
Who May Qualify
- Age 12-75 years
- Physician-diagnosed asthma for at least 12 months
- Uncontrolled asthma despite medium-to-high dose ICS plus LABA
- FEV1 40-90% predicted before bronchodilator
- Documented reversibility or positive methacholine challenge
- History of at least one exacerbation in past year
Who May Not Qualify
- Current smoker or >10 pack-year smoking history
- Other significant lung disease (COPD, bronchiectasis)
- Recent asthma exacerbation (within 4 weeks)
- Life-threatening asthma requiring intubation in past 5 years
- Maintenance oral corticosteroid use >10mg prednisone daily
Frequently Asked Questions
What asthma treatments are being studied?
+
Studies are evaluating new biologics targeting specific inflammatory pathways (IL-4, IL-5, IL-13, TSLP), novel inhaled therapies, and treatments for specific asthma phenotypes including eosinophilic and allergic asthma.
How are breathing tests performed?
+
Spirometry measures how much and how fast you can exhale. You will perform these tests at most visits, breathing into a device that measures lung function before and after using a bronchodilator.
Can I use my rescue inhaler during the study?
+
Yes, rescue inhalers (albuterol/salbutamol) are available throughout the study. The frequency of rescue inhaler use is actually tracked as one measure of asthma control.
What happens if I have an asthma attack during the study?
+
Exacerbations are treated according to standard protocols. Depending on severity, treatment may include increased controller medications or oral steroids. These events are important study outcomes.